RESUMO
Roussoella percutanea is a novel opportunistic pathogen firstly identified in 2014. It is known to cause subcutaneous infection in immunosuppressed patients. We report on the first case of R. percutanea bursitis in a renal transplant patient. We provide new data about its identification, drug susceptibility, and treatment outcome. Here we demonstrate that R. percutanea is a potential human pathogen.
Assuntos
Ascomicetos/classificação , Ascomicetos/isolamento & purificação , Bursite/diagnóstico , Bursite/patologia , Micoses/diagnóstico , Micoses/patologia , Antifúngicos/farmacologia , Antifúngicos/uso terapêutico , Ascomicetos/efeitos dos fármacos , Bursite/tratamento farmacológico , Bursite/microbiologia , DNA Fúngico/química , DNA Fúngico/genética , DNA Espaçador Ribossômico/química , DNA Espaçador Ribossômico/genética , Feminino , Humanos , Hospedeiro Imunocomprometido , Transplante de Rim , Testes de Sensibilidade Microbiana , Microscopia , Pessoa de Meia-Idade , Micoses/tratamento farmacológico , Micoses/microbiologia , Análise de Sequência de DNA , Transplantados , Resultado do TratamentoRESUMO
We report on two new cases Bordetella trematum in chronic ulcers. Literature shows that this species is infrequently isolated from clinical samples. Only a few cases have been reported so far. B. trematum may be underdiagnosed because of its problematic identification. Today, MALDI-TOF MS allows for an accurate discrimination of these bacteria. Overall, B. trematum was typically associated with severe skin and soft tissue infections, particularly in diabetic patients. The intrinsic resistance to some antibiotics commonly used to treat these infections makes the isolation of B. trematum significant.
